Unfortunately, a later study showed only transient benefits of IL-1R antagonists in a minor antigen-disparate murine model and no effects in a fully MHC disparate model (23), suggesting that other pro-inflammatory cytokines may be able to compensate for deficiencies in IL-1 signaling during acute GVHD. This evidence concerns the gene IL1A and graft versus host disease.